Altogether these data indicate that Derlin-2 is neither required for normal developmental myelination nor for remyelination after injury, but it appears to be protective in early stages of the CMT1B neuropathy. This evidence concerns the gene DERL2 and Charcot-Marie-Tooth disease type 1B.